Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. (DYN) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
DYN · net income · updated Jun 8, 2026
Core profitability metrics
DYN · net income · margin · TTM · CAGRNet income was −$446.2M for FY2025 (fiscal year ending 2025-12-31), down 40.6% year-over-year. Net profit margin was —. Based on available data, Dyne Therapeutics, Inc. has been profitable since at least 2012.
Annual net income history
▸ FMP /income-statement · Annual · DYN net income history · DYN profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Dyne Therapeutics, Inc. (DYN) reported net income of −$446.2M for FY2025 (fiscal year ending 2025-12-31), down 40.6% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Based on available data, Dyne Therapeutics, Inc. has been profitable since at least 2012. Net income reached a peak of $87.0M in FY2012. Data available for 15 fiscal years.
Dyne Therapeutics, Inc.'s net profit margin was — for FY2025, based on the latest annual results.
Investors sometimes search for "Dyne Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from DYN net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
DYN net income · 4 questionsDyne Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $446.2M for FY2025.
▸ Source: FMP /income-statement · GAAP · Dyne Therapeutics, Inc. · Dyne Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026